| Original language | English (US) |
|---|---|
| Pages (from-to) | 741-743 |
| Number of pages | 3 |
| Journal | Anesthesiology |
| Volume | 127 |
| Issue number | 5 |
| DOIs | |
| State | Published - Nov 1 2017 |
Funding
Dr. Hendrickx has received several forms of support from companies involved with inhaled agent delivery (lecture support, travel reimbursements, equipment loans, consulting fees, and meeting organizational support) including the following: AbbVie (North Chicago, Illinois), Acertys (Aartse-laar, Belgium), Air Liquide (Paris, France), Allied Healthcare (Staffordshire, United Kingdom), Armstrong Medical (Lincolnshire, Illinois), Baxter International (Deerfield, Illinois), Draeger (Lübeck, Germany), General Electric (Boston, Massachusetts), Hospithera (Bruxelles, Belgium), Heinen und Lowenstein (Hamburg, Germany), Innomediq (Aarschot, Belgium), Intersurgical (Berkshire, United Kingdom), Ma-quet (Rastatt, Germany), MDMS (New York, New York), MEDEC (Aalst, Belgium), Micropore (Newark, Delaware), Mindray (Shenzhen, China), Molecular Devices (Sunnyvale, California), Philips (Amsterdam, the Netherlands), Pira-mal (Mumbai, India), and Quantium Medical (Barcelona, Spain). Dr. Peyton holds two patents related to cardiac output monitoring. The other author declares no competing interests.
ASJC Scopus subject areas
- Anesthesiology and Pain Medicine